Qnexa Proposed REMS Focuses On Registry, Web-Based Physician Education

FDA advisory committee will hear Vivus' proposal for a voluntary pregnancy registry that could calculate the risk of major birth defects from the obesity drug; potential cardiovascular problems would be assessed in large outcomes trial.